Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Statera BioPharma Cash from Operations (Quarterly): -0.8015M for Sept. 30, 2022
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.8015M |
| June 30, 2022 | -0.1685M |
| March 31, 2022 | -3.762M |
| December 31, 2021 | -7.360M |
| Date | Value |
|---|---|
| September 30, 2021 | -15.22M |
| June 30, 2021 | -3.022M |
| March 31, 2021 | -2.592M |
| March 31, 2020 | -0.0016M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.22M
Minimum
Sep 2021
-0.0016M
Maximum
Mar 2020
-4.116M
Average
-2.807M
Median
Cash from Operations (Quarterly) Benchmarks
| Humanigen Inc | -7.059M |
| Cannabis Global Inc | -0.2384M |
| Item 9 Labs Corp | 0.1501M |
| Cantabio Pharmaceuticals Inc | -0.2582M |
| Affymax Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.7117M |